MMP9 and cancer: It has also been shown that upregulated MMP9 expression in the pre‐metastatic niche is attributed to endothelial cells, besides macrophages.9 However, our analysis of treatment using the MMP inhibitor in endothelial cells resulted in no disadvantages in extravasation rates of cancer cells.